GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 348 filers reported holding GUARDANT HEALTH INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,258 | -99.9% | 46,236 | +4.8% | 0.00% | -100.0% |
Q3 2022 | $2,376,000 | -20.5% | 44,139 | -40.4% | 0.00% | 0.0% |
Q2 2022 | $2,987,000 | -76.3% | 74,013 | -61.1% | 0.00% | -75.0% |
Q1 2022 | $12,607,000 | -41.6% | 190,301 | -11.9% | 0.00% | -42.9% |
Q4 2021 | $21,602,000 | -16.4% | 215,974 | +4.5% | 0.01% | -12.5% |
Q3 2021 | $25,833,000 | +3.5% | 206,682 | +2.8% | 0.01% | 0.0% |
Q2 2021 | $24,969,000 | -19.1% | 201,010 | -0.4% | 0.01% | -20.0% |
Q1 2021 | $30,847,000 | +21.3% | 201,819 | +2.2% | 0.01% | +11.1% |
Q4 2020 | $25,435,000 | +22.1% | 197,399 | +5.9% | 0.01% | 0.0% |
Q3 2020 | $20,831,000 | +50.2% | 186,380 | +9.0% | 0.01% | +50.0% |
Q2 2020 | $13,868,000 | +43.0% | 170,961 | +22.7% | 0.01% | +20.0% |
Q1 2020 | $9,699,000 | -2.1% | 139,310 | +9.9% | 0.01% | +25.0% |
Q4 2019 | $9,908,000 | +39.0% | 126,806 | +13.5% | 0.00% | +33.3% |
Q3 2019 | $7,127,000 | +43.0% | 111,691 | +93.4% | 0.00% | +50.0% |
Q2 2019 | $4,985,000 | – | 57,749 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |